Source: European Medicines Agency (EU) Revision Year: 2019 Publisher: Aerie Pharmaceuticals Ireland, Limited, Athlone Business and Technology Park, Dublin Road, Garrycastle, Athlone, Co Westmeath, N37 DW40, Ireland
Rhokiinsa 200 micrograms/ml eye drops, solution.
| Pharmaceutical Form |
|---|
|
Eye drops, solution (eye drops). Clear solution, pH 5 (approximately). |
Each ml of solution contains 200 micrograms netarsudil (as mesylate).
Excipient(s) with known effect: Each ml of solution contains 150 micrograms benzalkonium chloride.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Netarsudil |
Netarsudil, a Rho kinase inhibitor, is believed to reduce intraocular pressure (IOP) by increasing outflow of aqueous humor. Studies in animal and man suggest that the main mechanism of action is increased trabecular outflow. These studies also suggest that netarsudil lowers IOP by reducing episcleral venous pressure. |
| List of Excipients |
|---|
|
Benzalkonium chloride |
Rhokiinsa is supplied sterile in opaque white low density polyethylene bottles (2.5 ml fill in a 4 ml container) and tips with white polypropylene caps and anti-tamper seals.
Carton containing 1 bottle.
Aerie Pharmaceuticals Ireland, Limited, Athlone Business and Technology Park, Dublin Road, Garrycastle, Athlone, Co Westmeath, N37 DW40, Ireland
EU/1/19/1400/001
| Drug | Countries | |
|---|---|---|
| RHOKIINSA | Austria, Estonia, Croatia, Ireland, Italy, Lithuania, Poland |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
